PRINCIPLES OF PANDEMICS Flashcards

1
Q

DIFFERENCES BETWEEN AN ENDEMIC/OUTBREAK/EPIDEMIC AND PANDEMIC?

A

ENDEMIC: OBSERVED CASES ARE EXPECTED, A CONDITION HAS A STEADY RATE AMONG A POPULATION
OUTBREAK: INCREASE IN CASES, NOT EXPECTED, USUALLY CONCERNS A SMALL GEOGRAPHICAL AREA
EPIDEMIC: OUTBREAK OVER A LARGER GEOGRAPHICAL AREA
PANDEMIC: AN EPIDEMIC WITH A GLOBAL SPREAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

WHAT WAS THE MOST SEVERE PANDEMIC OF THE 20TH CENTURY?

A

THE SPANISH FLU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DESCRIBE THE SPANISH FLU PANDEMIC:

A
  • MOST SEVERE IN RECENT HISTORY WITH WORLDWIDE SPREAD IN 1918-1919
  • CCA 500 MILLION INFECTED
  • CCA 50 MILLION DEATHS
  • HIGH PREVALENCE IN <5, 20-40 AND 56+ YEAR OLDS
  • INTERVENTIONS: NON PHARMACEUTICAL (ISOLATION, QUARANTINE, HYGIENE, DISINFECTANTS..); NO VACCINE, NO ANTIVIRALS, NO ANTIBIOTICS (ALTHOUGH ANTIBIOTICS CAN’T HELP TREAT THE FLU AS IT IS A VIRAL INFECTION, PEOPLE WITH FLU CAN DEVELOP A BACTERIAL INFECTION BECAUSE OF THEIR COMPROMISED IMMUNE SYSTEM)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NAME THE INFLUENZA PANDEMICS IN THE 20TH AND THE 21ST CENTURY?

A
SPANISH FLU (1918-1919)
ASIAN FLU (1957-1958)
HONG KONG FLU (1968)
SWINE FLU (2009-2010)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 INFLUENZA PANDEMICS OF THE 20TH AND THE 21ST CENTURY THAT WERE CAUSED BY THE SAME VIRUS?

A

SPANISH FLU AND SWINE FLU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

WHEN WAS INFLUENZA FIRST ISOLATED AND SHOWN TO BE A VIRUS?

A

1930

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TIMELINE OF THE FLU VACCINATION IN THE UK?

A

1960s: SEASONAL VACCINE IN UK FOR HIGH RISK GROUPS
2000: SEASONAL VACCINE IN THE UK FOR THE 65+ YEAR OLDS
2013: VACCINE IN THE UK FOR CHILDREN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

WHAT DOES THE ‘BLACK DEATH’ REFER TO?

A

IN THE MIDDLE AGES, ‘BLACK DEATH’ WAS A BUBONIC PLAGUE PANDEMIC FROM 1346 TO 1353 CAUSING OVER 50 MILLION DEATHS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ORIGIN OF THE WORD ‘QUARANTINE’?

A
  • DERIVED FROM THE ITALIAN WORDS ‘QUARANTA GIORNI’ WHICH MEANS 40 DAYS
  • DURING BLACK DEATH (BUBONIC PLAGUE PANDEMIC), EUROPE WAS PARTICULARLY AFFECTED, ONE OF THE FIRST COUNTRIES BEING ITALY
  • IN 1348, VENICE BECAME THE FIRST CITY TO CLOSE ITS PORTS TO INCOMING VESSELS
  • THOSE THAT DID GET ADMITTED WERE SUBJECT TO 30 DAYS ISOLATION, LATER 40 DAYS, AND THAT’S HOW QUARANTINE GOT ITS NAME
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

IMPACTS OF BLACK DEATH (BUBONIC PLAGUE PANDEMIC IN THE MIDDLE AGES)?

A
  • LARGE SOCIAL AND ECONOMIC EFFECTS
  • PSYCHOLOGICAL EFFECTS: FAITH IN RELIGION DECLINES, SOME LIVED WILD, IMMORAL LIVES AS THEY HAD A PERCEPTION OF SOON, UNAVOIDABLE DYING
  • PEOPLE BEGAN TO HATE POVERTY AND THEIR ‘BETTERS’
  • EXTREME INFLATION
  • GOODS IN SHORT SUPPLY
  • WORKERS MORE EMPOWERED BECAUSE THE SHORTAGE MADE THEM ABLE TO CHOOSE WHO TO WORK FOR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

BLACK DEATH/BUBONIC PLAGUE PANDEMIC WAS CAUSED BY?

A

BY A BACTERIUM CALLED YERSINIA PESTIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DESCRIBE THE PATHOGEN: YERSINIA PESTIS?

A
  • BACTERIUM, USUALLY FOUND IN SMALL MAMMALS LIKE RATS AND THEIR FLEAS (VECTOR = RAT FLEA)
  • ZOONOTIC; CAN TRANSMIT FROM ANIMALS TO HUMANS BY BITE OF INFECTED FLEAS, DIRECT CONTACT WITH INFECTED TISSUES AND/OR INHALATION OF INFECTED RESPIRATORY DROPLETS
  • CAN BE TREATED WITH ANTIBIOTICS
  • gram-negative, non-motile, coccobacillus bacterium without spores, facultative anaerobe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 MAIN CLINICAL FORMS OF PLAGUE CAUSED BY YERSINIA PESTIS AND THEIR FATALITY?

A

BUBONIC (CHARACTERISED BY BUBOES; SWOLLEN LYMPH NODES) AND PNEUMONIC

  • BOTH CAN BE VERY SEVERE
  • CASE FATALITY RISK OF 30-60% FOR BUBONIC
  • ALWAYS FATAL FOR UNTREATED PNEUMONIC PLAGUE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

CRITERIA FOR PRIORITIZATION OF PATHOGENS (IN RESEARCH) WITH PANDEMIC POTENTIAL?

A
  • HUMAN TRANSMISSION
  • MEDICAL COUNTERMEASURES
  • SEVERITY
  • HUMAN/ANIMAL INTERFACE
  • PUBLIC HEALTH CONTEXT
  • POTENTIAL SOCIETAL IMPACTS
  • EVOLUTIONARY POTENTIAL
  • OTHER FACTORS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

WHAT ARE THE CURRENT WHO PRIORITY DISEASES? (BASED ON THEIR PUBLICH HEALTH RISK DUE TO THEIR EPIDEMIC POTENTIAL)

A
  • COVID 19
  • CRIMEAN CONGO HAEMORRHAGIC FEVER
  • EBOLA VIRUS DISEASE AND MARBURG VIRUS DISEASE
  • LASSA FEVER
  • MIDDLE EASTERN RESPIRATORY SYNDROME CORONAVIRUS (MERS Co-V) AND SEVERE ACUTE RESPIRATORY SYNDROME (SARS)
  • NIPAH AND HENIPAVIRAL DISEASES
  • RIFT VALLEY FEVER
  • ZIKA
  • DISEASE X
    (NOT AN EXHAUSTIVE LIST, DOESN’T INDICATE THE MOST LIKELY CAUSE OF THE NEXT EPIDEMIC, LIST REGULARLY UPDATED)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CONTRIBUTING FACTORS TO INCREASING PANDEMIC RISKS?

A
  • GLOBAL TRAVEL (INTERNATIONAL FLIGHTS MADE DISEASE SPREAD EASY; 4.2 BILLION PEOPLE TRAVELLED BY AIR IN 2018)
  • URBANISATION (MORE CROWDING, INCREASING NUMBER OF PEOPLE IN SMALL PLACES, CITIES OVERPOPULATED)
  • CLIMATE CHANGE (INCREASES RISK OF EXTREME EVENTS, LIKE FLOODING, WHICH ARE OFTEN ASSOCIATED WITH INFECTIOUS DISEASE AS IT INFLUENCES PATHOGENS AND THEIR VECTORS)
  • INCREASED HUMAN-ANIMAL CONTACT (AS PEOPLE MOVE INTO NEW AREAS, AS WELL AS THE NATIONAL AND INTERNATIONAL TRADE IN WILDLIFE)
  • HEALTH WORKER SHORTAGES (MAY LEAVE HEALTH SYSTEMS MORE VULNERABLE TO INFECTIOUS DISEASE OUTBREAKS. ESP IN LMIC)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

WHICH ANIMAL DID SARS-CoV-2 CAUSING COVID 19 ORIGINATE FROM? HOW HAS THIS BEEN DETERMINED?

A

FROM BATS (DETERMINED THROUGH GENETIC DATA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ORIGINS OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) AND MIDDLE EASTERN RESPIRATORY SYNDROME (MERS)?

A

SARS: 2002; ORIGINATED FROM BATS, BUT THEN PASSED THROUGH CIVET CATS AND ONTO HUMANS
MERS: 2012; MAY HAVE ORIGINATED FROM BATS, BUT WAS IN DROMEDARY CAMELS FOR A LONG TIME BEFORE IT WAS ABLE TO INFECT HUMANS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

WHEN DID CHINA ALERT WHO OF CLUSTER OF CASES OF PNEUMONIA OF UNKNOWN AETIOLOGY IN WUHAN?

A

31ST DECEMBER 2019

20
Q

WHEN WAS SARS CoV-2 (A NOVEL CORONAVIRUS) IDENTIFIED AS A SOURCE OF PNEUMONIA CASES ORIGINATING IN WUHAN, CHINA?

A

7TH JANUARY 2020

21
Q

WHAT DO REPORTED CASE RATES OF COVID 19 DEPEND ON AND HOW DOES THAT INFLUENCE THE NUMBERS?

A

DEPEND ON: TESTING CAPACITY, TESTING STRATEGY, TEST SEEKING BEHAVIOUR, TEST SENSITIVITY/SPECIFICITY
- DAILY NUMBER OF CONFIRMED CASES ALWAYS LOWER THAN THE ACTUAL NUMBER

22
Q

WHAT IS THE NUMBER OF COVID-19 PATIENTS IN HOSPITALS IN DIFFERENT COUNTRIES INFLUENCED BY?

A
  • HOSPITAL ADMISSION THRESHOLDS (WHICH ARE SIMILAR IN COUNTRIES WITH COMPARABLE HEALTHCARE SYSTEMS)
  • RISK FACTORS IN THE POPULATIONS (E.G. IS IT A PREDOMINANTLY OLD POPULATION, ARE THERE A LOT OF SMOKERS ETC)
  • INCIDENCE OF COVID 19
23
Q

WHY IS NUMBER OF CONFIRMED DEATHS FROM COVID-19 IN SOME COUNTRIES MUCH LOWER THAN THE TRUE NUMBER?

A
  • LIMITED TESTING FOR COVID
  • EXCLUSION OF CERTAIN GROUPS
  • CHALLENGES IN DETERMINING EXACT CAUSE OF DEATH ETC
24
Q

WHAT IS THE AIM OF PANDEMIC RESPONSE?

A
  • LIMIT ONWARD SPREAD TO CONTAIN THE EPIDEMIC AND(OR SLOW ITS PROGRESSION
  • ENSURE PROMPT AND APPROPRIATE CLINICAL CARE TO REDUCE MORBIDITY AND MORTALITY
  • IDENTIFY KNOWLEDGE GAPS AND DEVELOP TOOLS TO PREVENT DISEASE AND IMPROVE TREATMENTS (DRUGS, VACCINES)
  • LIMIT IMPACT IN TERMS OF HEALTH, ECONOMIC AND SOCIAL ASPECTS OF SOCIETY
25
Q

WHAT ARE THE STAGES OF EMERGENCY RESPONSE?

A
  1. PREVENTION + MITIGATION: HEALTH EMERGENCIES PREVENTED OR QUELLED
  2. PREPAREDNESS: CAPABILITY TO MANAGE EMERGENCY
  3. RESPONSE: EFFECTIVELY RESPOND TO SAVE LIVES (PANDEMIC PHASE)
  4. RECOVERY: SUSTAIN EFFORTS (TRANSITION PHASE)
26
Q

STAGES OF A PANDEMIC?

A

1) NO KNOWN CASES (FOCUS ON PREPARING, SURVEILLANCE, HEALTH CARE READY TO RESPOND
2) A FEW CASES OR SMALL CLUSTERS (FOCUS ON CONTAINMENT, BREAK TRANSMISSION CHAINS)
3) WIDESPREAD COMMUNITY TRANSMISSION (FOCUS ON SUPPRESSING AND MITIGATION; REDUCING TRANSMISSION, MORBIDITY AND MORTALITY, ENSURE HEALTH SERVICES CAN COPE)

27
Q

CONTRIBUTORS IN PANDEMIC RESPONSE?

A

INTERNATIONAL: WHO, UN AND OTHER ORGANISATIONS
NATIONAL: GOVERNMENTS
ORGANISATIONAL: HEALTH CARE, EDUCATION, PUBLIC ORGANISATIONS AND FOUNDATIONS, BUSINESSES

28
Q

WHO DECIDES AND BASED ON WHAT IF AN INFECTIOUS DISEASE OUTBREAK IS UNEXPECTED AND SPREADING INTERNATIONALLY AND MAY REQUIRE GLOBAL RESPONSE?

A
  • DIRECTOR GENERAL OF WHO
  • BASED ON: EPIDEMIOLOGICAL DATA INCLUDING INTERNATIONAL SPREAD, IMPACT ON TRADE AND TRAVEL, MAXIMUM PUBLIC HEATH SAFETY BUT WITH MINIMAL INTERFERENCE WITH TRAVEL AND TRADE
29
Q

WHAT ARE INTERNATIONAL HEALTH REGULATIONS (IHR)?

A
  • AN INTERNATIONAL LEGAL BINDING INSTRUMENT FOR 194 COUNTRIES ACROSS THE GLOBE, INCLUDING ALL THE MEMBER STATES OF WHO
  • ENTERED INTO FORCE ON 15 JUNE 2007
  • REQUIRE COUNTRIES TO REPORT CERTAIN DISEASE OUTBREAKS AND PH EVENTS TO WHO
30
Q

WHAT DOES ‘PHEIC’ STAND FOR?

A

PUBLIC HEALTH EMERGENCY OF INTERNATIONAL CONCERN, DECLARED BY WHO

31
Q

WHEN WAS COVID 19 DECLARED A PHEIC (PUBLIC HEALTH EMERGENCY OF INTERNATIONAL CONCERN) BY THE WHO?

A

30TH JANUARY 2020

32
Q

THE TERM PHEIC ORIGINATED FOLLOWING WHAT?

A

SARS OUTBREAK IN 2003

33
Q

WHEN DID WHO DECLARE COVID 19 A PANDEMIC?

A

11 MARCH 2020

34
Q

WHO IS THE DIRECTOR-GENERAL OF THE WORLD HEALTH ORGANISATION?

A

DR TEDROS ADHANOM GHEBREYESUS

35
Q

DESCRIBE THE AIMS OF RESPONSE TO COVID 19?

A
  • CONTAINMENT (AIM TO ELIMINATE COMMUNITY TRANSMISSION)
  • SUPPRESSION (MINIMIZE COMMUNITY INFECTIONS)
  • MITIGATION (AVOID OVERWHELMING HEALTHCARE)
36
Q

DESCRIBE THE STRATEGIES OF RESPONSE TO COVID 19?

A
  • CASE BASED INTERVENTIONS (TESTING AND CONTACT TRACING; RAPIDLY DETECT AND ISOLATE CASES, MONITOR CLOSE CONTACTS)
  • POPULATION BASED INTERVENTIONS (FACE MASKS, DISTANCING, CLOSURE OF HOSPITALITY, LIMIT GATHERINGS, WORK/STUDY REMOTELY AND FROM HOME)
  • BORDER CONTROL MEASURES (TRAVEL RESTRICTIONS, MANDATORY QUARANTINE)
37
Q

LIST THE ACTIONS FOR EMERGENCY RESPONSE FOR A PANDEMIC?

A
  • PLANNING AND COORDINATION (RESPONSE PLAN, SURVEILLANCE, LEADERSHIP, DIRECT RESEARCH, GIVE RESOURCES..)
  • SITUATION MONITORING AND ASSESSMENT (MONITOR TRENDS, ANALYSE DATA, MODEL PROJECTIONS, DEVELOP/TEST NEW TOOLS)
  • COMMUNICATION FOR INFORMATION AND INTERVENTIONS (GUIDELINES TO HCPs AND PH WORKERS, COMMUNICATE PLANS)
  • REDUCE THE SPREAD OF DISEASE (CONTAINMENT, INDIVIDUAL BEHAVIOURS AND SOCIETAL BEHAVIOURS)
  • CONTINUITY OF HEALTHCARE PROVISION (PLANS FOR SCALE UP OF HEALTHCARE, INFECTION PREVENTION AND CONTROL, DELIVERY OF DRUGS AND VACCINES)
38
Q

STAGES OF VACCINE DEVELOPMENT?

A

DISCOVERY (DEVELOPMENT OF THE VACCINE)
PHASE 1 (GIVEN TO A SMALL GROUP OF HEALTHY INDIVIDUALS FOR INITIAL SAFETY DATA)
PHASE 2 (DETERMINE SAFETY EFFECTIVENESS)
PHASE 3 (SAFETY AND EFFECTIVENESS, DOSE, SIDE EFFECTS, RCT)
REGULATORY (REVIEW AND APPROVAL)
PHASE 4 (SURVEILLANCE FOR ADVERSE EVENTS, NEW FORMULATIONS)

39
Q

GIVE SOME EXAMPLES OF DRUGS THAT WERE CONSIDERED AS A POTENTIAL TREATMENT FOR COVID 19?

A

CHLOROQUINE/HYDROXYCHLOROQUINE: USED IN MALARIA, EARLY SUGGESTIONS OF BENEFIT IN SOME PEOPLE WITH COVID IN CHINA AND FRANCE, BUT NO BENEFIT WITH SUBSEQUENT RCTs

REMDESIVIR: PREVIOUSLY TESTED IN EBOLA, SOME SUGGESTIONS OF BENEFIT FROM RESULTS IN ANIMAL STUDIES FOR MERS-CoV AND SARS, DATA FROM RCTs SHOWED A FASTER TIME TO CLINICAL IMPROVEMENT IN THOSE SEVERELY ILL WITH COVID-19 AND THE DRUG HAS SINCE BEEN APPROVED FOR USE IN COVID 19

40
Q

GIVE EXAMPLE OF A DRUG THAT HAS BEEN APPROVED FOR USE IN COVID 19?

A

REMDESIVIR

41
Q

WHAT IS THE ‘RECOVERY’ CLINICAL TRIAL?

A
  • RANDOMISED EVALUATION OF COVID-19 THERAPY
  • AIMING TO ASSESS IMPROVED OUTCOMES
  • ENROLLED ADULTS PATIENTS IN HOSPITAL WITH COVID-19 COMPARING STANDARD OF CARE+ONE OF THE 4 TREATMENTS VS STANDARD OF CARE ALONE
  • HAS INCLUDED MANY TREATMENTS (E.G. STEROIDS, HIV MEDICATION, CHLOROQUINE, SOME ANTIBIOTICS)
  • CURRENTLY TESTING SOME TREATMENTS: HIGH-DOSE VS STANDARD CORTICOSTEROIDS, EMPAGLIFLOZIN (A DRUG FOR DIABETES AND HEART AND KIDNEY DISEASE), SOTROVIMAB (A MONOCLONAL ANTIBODY TREATMENT AGAINST THE SPIKE PROTEIN)
42
Q

NAME SOME OF THE DRUGS THE ‘RECOVERY’ CLINICAL TRIAL IS CURRENTLY TESTING AS POTENTIAL TREATMENTS FOR COVID 19:

A
  • HIGH-DOSE VS STANDARD CORTICOSTEROIDS
  • EMPAGLIFLOZIN (A DRUG FOR DIABETES AND HEART AND KIDNEY DISEASE)
  • SOTROVIMAB (A MONOCLONAL ANTIBODY TREATMENT AGAINST THE SPIKE PROTEIN)
43
Q

EXAMPLES OF COUNTRIES THAT HAVE FOCUSED ON CONTAINMENT (AIM TO ELIMINATE COMMUNITY TRANSMISSION) IN THEIR RESPONSE TO COVID?

A

ASIAN AND PACIFIC COUNTRIES SUCH AS CHINA, NEW ZEALAND AND SINGAPORE

44
Q

EXAMPLES OF COUNTRIES THAT HAVE FOCUSED ON SUPPRESSION (MINIMIZE COMMUNITY INFECTIONS) IN THEIR RESPONSE TO COVID 19?

A

UNITED STATES, ARGENTINA

45
Q

EXAMPLES OF COUNTRIES THAT HAVE FOCUSED ON MITIGATION (AVOID OVERWHELIMING HEALTHCARE) IN THEIR RESPONSE TO COVID 19?

A

SWEDEN

46
Q

FACTORS ENSURING SUCCESSFUL CONTAINMENT OF COVID 19?

A
  • POLITICAL COMMITMENT
  • PREPAREDNESS
  • SCIENTIFIC INPUTS
  • TRUST
  • COMMUNITY ENGAGEMENT
  • SOCIOECONOMIC SUPPORT
  • BORDER CONTROL SUPPORT
  • MEASURES TO SURGE CAPACITY
47
Q

DESCRIBE THE CONSEQUENCES/IMPACTS OF COVID-19?

A
  • ECONOMIC IMPACT (LOSS OF EMPLYMENT IMPACTING MENTAL AND PHYSICAL HEALTH)
  • SOCIAL ISOLATION INFLUENCING MENTAL HEALTH + PRACTICAL DIFFICULTIES, RELATIONSHIPS, EXPLOITATION, HEALTH DAMAGING BEHAVIOURS
  • DISRUPTION OF ESSENTIAL SERVICES (HEALTHCARE, EDUCATION)
  • TRANSPORT
  • SOCIAL DISORDER (PEOPLE LOOKING FOR WHO TO BLAME, STIGMA..)
  • PSYCHO-SOCIAL IMPACT AND FEAR AND ANXIETY WHICH MIGHT BE BARRIERS TO THE RETURN TO NORMALITY
  • SOCIETAL CHANGE
  • OPPORTUNITY TO FACE PROBLEMS OF SOCIETY